Pfizer Inc.
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 54.2B 58.5B 100.3B 81.3B
Cost of revenue 15.2B 25.0B 34.3B 30.8B
Gross profit 39.0B 33.5B 66.0B 50.5B
Operating expense
Research & development 9.3B 10.7B 11.4B 10.4B
Selling general and admin 12.6B 14.8B 13.7B 12.7B
Other operating expenses
Operating income 12.6B 3.4B 37.3B 23.7B
Non operating interest income
Income 464.5M 1.6B 251M 36M
Expense 2.6B 2.2B 1.2B 1.3B
Other income expense -3.6B -1.7B -1.6B 1.8B
Pretax income 6.8B 1.1B 34.7B 24.3B
Tax provision -23.9M -1.1B 3.3B 1.9B
Net income 6.9B 2.2B 31.4B 22.0B
Basic EPS 1.4 0.4 5.6 3.9
Diluted EPS 1.4 0.4 5.5 3.9
Basic average shares 4.8B 5.9B 5.8B 5.8B
Diluted average shares 4.8B 5.9B 5.8B 5.8B
EBITDA 19.3B 14.4B 45.1B 33.6B
Net income from continuing op. 6.9B 2.2B 31.4B 22.5B
Minority interests -31M -39M -35M -45M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 50 minutes

11:44
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).